Veru Inc. updates on its Phase 2b clinical trials ... the Company plans to partner with the Colorado Prevention Center, Aurora, Colorado and Lundquist Institute, Torrence, California.

Property giant Ayala Land Inc. (ALI) is set to open a key lifestyle and commercial destination in the south by the end of the ...

Leo Pharma has shared phase 2b data on its eczema prospect temtokibart, reporting that the top three doses of the IL-22RA1 blocker beat placebo on the primary endpoint. Temtokibart is designed to ...

FOSTER CITY, Calif., May 12, 2025 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced the initiation of a Phase 2b clinical trial of TPX-100 ...

Marea Therapeutics has linked its lead candidate to a 53% placebo-adjusted mean reduction in remnant cholesterol, positioning the biotech to start a phase 2b trial imminently. San Francisco-based ...

The single-center, double-blinded Phase 2b challenge study enrolled 165 healthy adults, who were randomized 1:1 to receive Vaxart’s monovalent oral pill vaccine candidate targeting the norovirus GI.

Completion of dosing for 5,041 subjects in the Phase 2b NAVIGATE clinical trial, indicating significant progress in the development of CD388 for influenza prevention. Publication of preclinical ...

“Publication of the Phase 2b SYMMETRY trial results in the New England Journal of Medicine is a significant milestone that affirms the strength of our clinical data and the potentially transformative ...

A lot of them went even if the weather wasn’t necessarily the best,” he added. At the Ayala Center’s The Terraces leg the following day, Cueshé returned to Sonata with a nostalgia-filled ...

CORPUS CHRISTI, Texas — The Corpus Christi Fire Department is moving ahead with phase two of its Resource Center project, with a clear focus: protecting equipment and supporting firefighter ...

Robin announced that top-line data from the 16-week induction period of the REZOLVE-AD Phase 2b study will be shared in June 2025, with the 36-week maintenance period results expected in early 2026.

LEO Pharma A/S, a global leader in medical dermatology, today announced positive topline results of the phase 2b trial with temtokibart ... visit our privacy center. Maintaining independence ...